SCHEMBL14724679

SCHEMBL14724679

Cc1ccc(C(=O)NCc2nccs2)cc1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H4 Q96RI1 1/20 0.53
▸ ROCK2 O75116 1/20 0.52
▸ PSMD14 O00487 1/20 0.51
▸ STAMBP O95630 1/20 0.51
▸ COPS5 Q92905 1/20 0.51
▸ KDM4E B2RXH2 3/20 0.49
▸ KMT2A Q03164 3/20 0.47
▸ MAPK14 Q16539 1/20 0.47
▸ ADORA2A P29274 2/20 0.46
▸ ADORA1 P30542 1/20 0.46
▸ NPC1 O15118 3/20 0.46
▸ PIK3CA P42336 1/20 0.46
▸ RAB9A P51151 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ MEN1 O00255 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ PPARG P37231 1/20 0.44
▸ NCOA2 Q15596 1/20 0.44
▸ NCOA1 Q15788 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13102338 0.85 SMN1; SMN2 (0.62) ROCK2PSMD14STAMBPCOPS5KDM4E
SCHEMBL1119373 0.79 RAB9A (0.71) KMT2AADORA2AADORA1NPC1RAB9A
SCHEMBL13118304 0.79 NPC1 (0.60) ROCK2PSMD14STAMBPCOPS5KDM4E
SCHEMBL1568306 0.79 ROCK2 (0.57) ROCK2PSMD14STAMBPCOPS5KDM4E
SCHEMBL31468438 0.78 PSMD14 (0.57) ROCK2PSMD14STAMBPCOPS5KMT2A
SCHEMBL5112470 0.78 MAPK14 (0.63) MAPK14
SCHEMBL3643938 0.77 PSMD14 (0.56) ROCK2PSMD14STAMBPCOPS5KDM4E
SCHEMBL18085951 0.77 ROCK2 (0.58) ROCK2PSMD14STAMBPCOPS5ADORA2A
SCHEMBL1393311 0.77 NPC1 (0.64) NR1H4ROCK2PSMD14STAMBPCOPS5
SCHEMBL13947279 0.77 KDM4E (0.79) KDM4EKMT2AMAPK14NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836174-B2 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC (US) 2019-10-02 — — EP disclosed
EP-1836174-B1 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC (US) 2013-02-27 — — EP disclosed
Send feedback